TY - JOUR
KW - Administration, Sublingual
KW - Adult
KW - Analgesics, Opioid/administration & dosage
KW - buprenorphine
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Buprenorphine/administration & dosage
KW - Drug Abuse
KW - Drug Administration Routes
KW - Drug formulations
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Narcotic Antagonists/administration & dosage
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy/metabolism
KW - Poison Control Centers/statistics & numerical data
KW - Substance-Related Disorders
KW - Tablets
KW - United States
AU - S. F. Butler
AU - R. A. Black
AU - S. G. Severtson
AU - R. C. Dart
AU - J. L. Green
A1 - 
BT - Journal of substance abuse treatment
C5 - Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2017.10.010
JF - Journal of substance abuse treatment
PB - Elsevier Inc
PP - United States
PY - 2018
SN - 1873-6483; 0740-5472
SP - 42
EP - 49
EP - 
T1 - Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV(R) substance use disorder treatment centers and RADARS(R) System Poison Centers
T2 - Journal of substance abuse treatment
TI - Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV(R) substance use disorder treatment centers and RADARS(R) System Poison Centers
U1 - Opioids & Substance Use
U2 - 29195592
U3 - 10.1016/j.jsat.2017.10.010
VL - 84
VO - 1873-6483; 0740-5472
Y1 - 2018
ER -